Magnesium hydroxide.

The hepatic 25-hydroxylase and renal 1-alpha-hydroxylase steps that convert vitamin D to its active form are magnesium-dependent, as is the vitamin D binding protein's handling of the metabolites. Low magnesium status therefore blunts the response to a vitamin D dose. This is settled biochemistry and applies to any magnesium salt that raises status, including this one.

Calcium and magnesium compete for the same paracellular and transcellular routes across the intestine, so a large single dose of one blunts uptake of the other taken at the same moment. Separating them across the day sidesteps most of it. At usual dietary intakes the competition is minor. It matters at supplement-sized boluses.

Magnesium hydroxide neutralises stomach acid, and non-heme iron needs an acidic stomach to stay soluble before it reaches the duodenum. Taking an iron supplement alongside an antacid dose of magnesium hydroxide lowers the fraction absorbed. Two to four hours of separation is the standard workaround.

Ferrous sulfate depends on an acidic gastric environment to stay in the absorbable ferrous state. Raising gastric pH pushes it toward insoluble ferric hydroxide species. This is the most clinically relevant negative pairing for anyone using magnesium hydroxide as an antacid while also correcting low iron status.

Zinc shares transport routes with magnesium and calcium at the enterocyte, and its solubility also drops as gastric pH rises. A large magnesium hydroxide dose taken with zinc reduces zinc uptake on both counts. Dose separation is the practical answer.

Food-bound B12 has to be freed by gastric acid and pepsin before intrinsic factor can bind it. Sustained acid neutralisation reduces that release, which is why long-running antacid use is linked with lower B12 status. Crystalline B12 in a supplement is not protein-bound, so it is far less affected.

Betaine hydrochloride is taken to lower gastric pH and magnesium hydroxide is taken to raise it. Taken together they neutralise each other and both doses are wasted. Anyone using both is working against themselves and should pick one purpose per meal.

The two are combined in antacid tablets because their gastrointestinal side effects run opposite ways: magnesium salts loosen stools and calcium carbonate tightens them. The pairing balances that while both contribute acid neutralisation. This is a formulation convention with a long history.

Magnesium hydroxide works osmotically by holding water in the lumen. Psyllium holds water in a gel matrix. Used together the stool-softening effect stacks and adequate fluid intake becomes more important. Worth knowing before someone doubles up without meaning to.

Magnesium depletion opens ROMK channels in the distal nephron and drives renal potassium loss, which is why low potassium that will not correct often will not until magnesium status is restored. Any salt that raises magnesium status is relevant here. This is standard clinical physiology.

A randomised trial paired L-carnitine with magnesium hydroxide in adults with elevated liver fat and reported improvements in liver-related blood markers versus control. Those are markers, not clinical outcomes, and the design cannot separate which of the two components did the work. It is the only combination trial of this specific salt worth naming.

Both raise gastric pH, bicarbonate quickly and briefly, magnesium hydroxide more slowly and for longer. Combining them stacks the pH effect and, with it, every pH-dependent absorption issue listed above. Bicarbonate also adds a sodium load that matters for some people.